Ophthalmic diagnostic device maker ObjectiVision’s amended claims for damages, filed after a 25-day patent hearing, are “outlandish” and “unfair,” the University of Sydney has told the Federal Court.
The final day of trial in the ACCC’s case over muscle gel Voltaren wrapped up Wednesday with a barrister for GlaxoSmithKline slamming as ‘onerous’ a compliance regime proposed by the consumer watchdog and blasting an injunction as unnecessary for a problem the pharmaceutical giant ‘inherited’ from Novartis.
The first day of a liability hearing in a consumer case over GlaxoSmithKline’s marketing for its popular Voltaren products has seen an ACCC witness deflect accusations the regulator was vague about its misleading packaging concerns, placing the blame squarely on the pharmaceutical giant.
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company’s founder.
A former executive of hospital operator Healthe Care Pty has been charged with three counts of insider trading, the Australian Securities and Investments Commission said Monday.
The ACCC has brought a cartel case against biologics company Cryosite for agreeing to coordinate with competitor Cell Care prior to the completion of their merger agreement.
Biotech giant CSL has lost its challenge to a Fair Work Commission decision that found it unfairly sacked one of its workers deemed too sick to carry on with his duties.
The Fair Work Commission has thrown out an unfair dismissal case by a Sydney-based hospital employee who was fired after an unsolicited and “highly offensive” Instagram message to a young nurse.
The Australian Competition and Consumer Commission is seeking special leave from the High Court to appeal a ruling in a case alleging drug giant Pfizer misused its market power ahead of the expiration of its patent for Lipitor.
A Federal Court judge has dismissed proceedings by US pharma giant Geneva Laboratories against disgraced Sydney pharmacist Mina Attia over sales of 1,000 counterfeit Bio-Oil skincare bottles, calling it “madness” and a misuse of the court.